DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Peet M, Horrobin DF.
A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms.
J Psychiatr Res 2002;
36: 7-18
We do not assume any responsibility for the contents of the web pages of other providers.